Synapse - Larry Norton

Results (183)

A randomized phase 2 study of peri-operative ipilimumab, nivolumab and cryoablation versus standard care in women with residual, early stage/resectable, triple negative breast cancer after standard-of-care neoadjuvant chemotherapy

Meeting Abstract

McArthur, H.; Comen, E.; Bryce, Y.; Solomon, S. B.; Leal, J.; Rodine, M.; Abaya, C. D.; Patil, S.; Page, D.; Norton, L.
Cancer Research (2020)

Fulltext@MSK | Save

PD-L1 expression in tumor-infiltrating lymphocytes of invasive breast carcinoma

Meeting Abstract

Hoda, R.; Brogi, E.; Grabenstetter, A.; Patil, S.; Selenica, P.; Weigelt, B.; Reis-Filho, J.; Traina, T.; Robson, M.; Norton, L.; more...
Laboratory Investigation (2020)

Fulltext@MSK | Save

Efficacy and safety of gemcitabine with trastuzumab and pertuzumab after prior pertuzumab-based therapy among patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: A phase 2 clinical trial

Journal Article

Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P.; Fornier, M. N.; Goldfarb, S.; Jhaveri, K.; more...
JAMA Network Open (2019)

Fulltext@MSK | Save

A randomized phase II study of peri-operative ipilimumab, nivolumab and cryoablation versus standard care in women with residual, early stage/resectable, triple negative breast cancer after standard-of-care neoadjuvant chemotherapy

Meeting Abstract

McArthur, H. L.; Comen, E. A.; Bryce, Y.; Solomon, S. B.; Leal, J. H. S.; Rodine, M.; Abaya, C. D.; Patil, S.; Page, D. B.; Norton, L.
Annals of Oncology (2019)

Fulltext@MSK | Save

Preoperative checkpoint inhibition (CPI) and cryoablation (Cryo) in women with early-stage breast cancer (ESBC)

Meeting Abstract

Comen, E. A.; Bryce, Y.; Page, D. B.; Solomon, S. B.; Rodine, M.; Abaya, C. D.; Morris, E. A.; Plitas, G.; El-Tamer, M.; Gemignani, M.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

A randomized phase II study of peri-operative ipilimumab, nivolumab and cryoablation versus standard peri-operative care in women with residual triple negative early stage/resectable breast cancer after standard-of-care neoadjuvant chemotherapy

Meeting Abstract

McArthur, H. L.; Comen, E. A.; Solomon, S.; Rodine, M.; DiLauro Abaya, C.; Leal, J. H. S.; Patil, S.; Norton, L.
Cancer Research (2019)

Fulltext@MSK | Save

Tumor epichaperome expression using (124)I PU-H71 PET (PU-PET) as a biomarker of response for PU-H71 plus nab-paclitaxel in HER2 negative (HER2-) metastatic breast cancer (MBC)

Meeting Abstract

Jhaveri, K.; Dunphy, M.; Wang, R.; Comen, E.; Fornier, M.; Moynahan, M. E.; Bromberg, J.; Ma, W.; Patil, S.; Taldone, T.; more...
Cancer Research (2019)

Fulltext@MSK | Save

Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with human epidermal growth receptor 2 overexpressing metastatic breast cancer: 5-year follow-up

Journal Article

Wang, R.; Smyth, L. M.; Iyengar, N.; Chandarlapaty, S.; Modi, S.; Jochelson, M.; Patil, S.; Norton, L.; Hudis, C. A.; Dang, C. T.
The Oncologist (2019)

Fulltext@MSK | Save

Pathologic complete response rate according to HER2 detection methods in HER2-positive breast cancer treated with neoadjuvant systemic therapy

Journal Article

Krystel-Whittemore, M.; Xu, J.; Brogi, E.; Ventura, K.; Patil, S.; Ross, D. S.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; more...
Breast Cancer Research and Treatment (2019)

Fulltext@MSK | Save

Phase I study of intermittent high-dose lapatinib alternating with capecitabine for HER2-positive breast cancer patients with central nervous system metastases

Journal Article

Morikawa, A.; de Stanchina, E.; Pentsova, E.; Kemeny, M. M.; Li, B. T.; Tang, K.; Patil, S.; Fleisher, M.; Van Poznak, C.; Norton, L.; more...
Clinical Cancer Research (2019)

Fulltext@MSK | Save